Postmarketing studies of drug safety

被引：8
|
作者：
Schneeweiss, Sebastian
Avorn, Jerry
机构：
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2011年 / 342卷
关键词：
CLINICAL-TRIALS;
D O I：
10.1136/bmj.d342
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The role of databases in drug postmarketing surveillance
    Rodriguez, EM
    Staffa, JA
    Graham, DJ
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2001, 10 (05) : 407 - 410
  • [2] US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018
    Skydel, Joshua J.
    Zhang, Audrey D.
    Dhruva, Sanket S.
    Ross, Joseph S.
    Wallach, Joshua D.
    CLINICAL TRIALS, 2021, 18 (04) : 488 - 499
  • [3] A descriptive analysis of postmarketing requirement studies and clinical trials
    Choi, Lauren
    Etchey, Beverly
    Billings, Monisha
    Lee, Cathryn
    Weil, Kathleen M.
    Boxwell, Debra
    Edelberg, Helen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [4] Patient Nonadherence in Clinical Trials: Could There Be a Link to Postmarketing Patient Safety?
    Smith, Dorothy L.
    DRUG INFORMATION JOURNAL, 2012, 46 (01): : 27 - 34
  • [5] Patient Nonadherence in Clinical Trials: Could There Be a Link to Postmarketing Patient Safety?
    Dorothy L. Smith
    Drug information journal : DIJ / Drug Information Association, 2012, 46 : 27 - 34
  • [6] New Drug Postmarketing Requirements and Commitments in the US: A Systematic Review of the Evidence
    Moneer, Osman
    Brown, Beatrice L.
    Avorn, Jerry
    Darrow, Jonathan J.
    Mitra-Majumdar, Mayookha
    Joyce, Krysten W.
    Ross, Murray
    Pham, Catherine
    Kesselheim, Aaron S.
    DRUG SAFETY, 2022, 45 (04) : 305 - 318
  • [7] Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: Postmarketing surveillance report of 7740 patients
    Koike, Takao
    Harigai, Masayoshi
    Ishiguro, Naoki
    Inokuma, Shigeko
    Takei, Syuji
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Haruna, Shigenori
    Ushida, Naoko
    Kawana, Katsuyoshi
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2014, 24 (03) : 390 - 398
  • [8] Drug Safety Sciences and the Bottleneck in Drug Development
    Watkins, P. B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (06) : 788 - 790
  • [9] Postmarketing Modifications of Drug Labels for Cancer Drugs Approved by the US Food and Drug Administration Between 2006 and 2016 With and Without Supporting Randomized Controlled Trials
    Shepshelovich, Daniel
    Tibau, Ariadna
    Goldvaser, Hadar
    Molto, Consolacion
    Ocana, Alberto
    Seruga, Bostjan
    Amir, Eitan
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (18) : 1798 - +
  • [10] Safety of the Russian antiviral drug Kagocel
    Borovskaya, T. G.
    TERAPEVTICHESKII ARKHIV, 2017, 89 (11) : 93 - 99
12345